Navigation Links
Australian Scientists Develop Novel Drug To Combat Inflammatory Diseases

Researchers from Garvan Institute of Medical Research, Sydney have expressed hope over their newly developed drug to combat a severe inflammatory disease, rheumatoid arthritis. //It is also claimed to improve the clinical outcome in patients with asthma, multiple sclerosis, heart attack, sepsis, psoriasis and post transplant recipients.

The unique drug formulation has been tested on animal models (mice) and promising results have been obtained. It has been found to provide a dramatic pain reduction. In addition, it also promoted the general health status of the sufferer.

The identification of a specific mechanism by which the circulating while blood cells release toxic substances into the joints, causing joint damage is said to have triggered the discovery. Following injection of the new drug, the diseased tissue is restored back to the normal state within hours.

The ability of the drug to reverse the disease process in affected mice is remarkable. The development of this drug is believed to be a major milestone in the treatment of rheumatoid arthritis. The researchers have however warned that this prospective drug treatment cannot be considered a cure as the disease can relapse sometime later.

The researchers are now eagerly looking forward to conducting an extensive human clinical trial in volunteers to determine the safety and efficacy of the drug. This proposal is expected to be materialized in the next 18 months.


'"/>




Page: 1

Related medicine news :

1. Australian Scientists Silence Cancer Gene
2. Australian Government To Stockpile Anti-Bird Flu Drug Relenza
3. Australian Company Gets $10 million For Developing Skin Cancer Gel
4. Australian Health funds stand accused
5. Australian Court Finds Man Guilty of Spreading HIV/AIDS
6. Sale Of Bird Flu Vaccine to US Planned: Australian Firm
7. Hepatitis C Could Infect 800,000 Australians By 2020
8. Obesity Cost More Than The Australian Health Budget
9. Australian Snake Venom Can Arrest Bleeding During Surgery And Trauma
10. Fat Virus, Ad-36 Blamed For Obesity Epidemic In Australians
11. Its High Time the Australian Government Takes Steps against Diabetes

Post Your Comments:
(Date:11/26/2009)... of Americans living with diabetes will nearly dou...million in 2034. Over the same period, spending on...lion to $336 billion, even with no increase in the...niversity of Chicago report in the December issue ...iabetes covered by Medicare will rise from 8.2 mil...
(Date:11/26/2009)...n emotional rollercoaster, study finds , ...he fear factor meets the jubilant sports fan. ,...y those who root for the winning team -- enjoy the... match and victory was in doubt, producing feeling...s Thanksgiving weekend as you,re glued to the TV s...
(Date:11/26/2009)... Triangle Dental (RTDental), a leading dental grou...ced the expansion of its services to include LUMIN...millan. , Durham, NC (...nnounce that Dr. Doug Macmillan, an experienced L...l advanced training seminar. RTDental’s abi...
(Date:11/25/2009)... When most people hear t...a chiropractor can also give patients the help the...nt, which is where your jaw (mandible) contacts/co... most common symptoms associated with TMJ dysfunct...the jaw. But many other symptoms can be caused fr...
(Date:11/25/2009)...RNewswire/-SentinelleMedicalInc.,aleadingmanufactu...andCalgaryScientificInc.,aleadingproviderofsoftwar...egis(TM)Breast4DAdvancedVisualizationsoftware. ,...printWebclientbasedmedicalimagingofferinginthemark...zero-footprintaccess-requiringnosoftwaredownload,a...
Breaking Medicine News(10 mins):Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3
...,Inc. (NYSE: SRZ ) today announced that the previ...f Arcapita Inc. and Health Care REIT (HCN), under,... venture owning 29 senior,housing properties manag...inue to manage the properties under long term,cont...
...stCall/ -- Emerald Dairy,Inc. (OTC Bulletin Board:...ed the terms of its offer to existing warrant hold...he offer to exercise the warrants on,amended terms...ts to purchase approximately 8.0 million shares ar...
...contacts boost odds of bacterial infection , ...oween, don,t put anything in your eye unless it ha...warning from the American Optometric Association (...lates decorative lenses as a medical device, some ...
...e Access to Brand and,Generic Medications as well ...rScript Insurance,Company, a subsidiary of CVS Car...continue to offer a variety of Medicare Prescripti...ending on their,individual health care needs and b...
...ia-Pacific trials to be, presented at 59th Annual ... of Liver Diseases -, WAY...althCare Pharmaceuticals, Inc. and Onyx Pharmaceut...or the Study,of Live Diseases (AASLD) demonstratin...
... three,well-received healthy snacks for on-the-go ...est additions to its healthy snacks available now ... food to fit their own style,and schedule. Continu...ttan" snack and "Power-Up" snack follow the same h...
Other Medicine News:Health News:Sunrise Provides Update on HCN Transaction 2Health News:Sunrise Provides Update on HCN Transaction 3Health News:Sunrise Provides Update on HCN Transaction 4Health News:Emerald Dairy Extends Terms of Offer for Early Exercise of Warrants 2Health News:Decorative Halloween Eye Lenses May Pose Serious Risks 2Health News:SilverScript Insurance Company, a CVS Caremark Company, Provides Variety of Medicare Prescription Drug Plan Options for 2009 2Health News:SilverScript Insurance Company, a CVS Caremark Company, Provides Variety of Medicare Prescription Drug Plan Options for 2009 3Health News:New Analyses Confirm Nexavar's Efficacy and Safety in Multiple Patient Subsets With Liver Cancer 2Health News:New Analyses Confirm Nexavar's Efficacy and Safety in Multiple Patient Subsets With Liver Cancer 3Health News:New Analyses Confirm Nexavar's Efficacy and Safety in Multiple Patient Subsets With Liver Cancer 4Health News:New Analyses Confirm Nexavar's Efficacy and Safety in Multiple Patient Subsets With Liver Cancer 5Health News:New Analyses Confirm Nexavar's Efficacy and Safety in Multiple Patient Subsets With Liver Cancer 6Health News:Lifestyle Foods Introduces Two New Healthy Snack Options 2
(Date:11/27/2009)... ACUO TECHNOLOGIES, developers of h... data migration tools and services, is pleased to ...rk Office has approved a patent application for an...work." Acuo Technologies is pleased to add the U.S.... In general, the granted patent application broad...
(Date:11/25/2009)...5 American Scientific Re...s pleased to announce that they have opened a regi... Shanghai, China. ,, ASR has been able to secur...y for the development and production of current an...nd adults to be distributed and sold globally. Cu...
(Date:11/25/2009)... ERT (Nasdaq: ERES ), a...ompany,s President and CEO, and Keith Schneck, the...cheduled to present at the 21st Annual Piper Jaffr...er 1, 2009 in New York City, New York. ,, Inter...ing the Company,s corporate website at http://www...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2American Scientific Resources Inc. Opens Shanghai Location 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Materials and Processes for Medical Devices Event Brings Clinicians Engineers Designers Together 50574 1Materials and Processes for Medical Devices Event Brings Clinicians Engineers Designers Together 50574 2Materials and Processes for Medical Devices Event Brings Clinicians Engineers Designers Together 50574 3Materials and Processes for Medical Devices Event Brings Clinicians Engineers Designers Together 50574 4New Partnership Between FirstCare and HealthFitness Provides Cost Effective Preventive Health Solutions for Small to Mid Size Companies 50570 1New Partnership Between FirstCare and HealthFitness Provides Cost Effective Preventive Health Solutions for Small to Mid Size Companies 50570 2New Partnership Between FirstCare and HealthFitness Provides Cost Effective Preventive Health Solutions for Small to Mid Size Companies 50570 3New Partnership Between FirstCare and HealthFitness Provides Cost Effective Preventive Health Solutions for Small to Mid Size Companies 50570 4FDA Tells Patients to Stick With Diabetes Drug Linked to Cancer 50566 1FDA Tells Patients to Stick With Diabetes Drug Linked to Cancer 50566 2
...atients Showing Excellent Tolerability at Higher D... 20 Bionovo, Inc.,(Nasdaq: BNVI ) today announce...ancer drug candidate, BZL101 were well tolerated. ...e escalation portion of the study longer,than prev...he maximum tolerated dose earlier, and then,transi...
... Review Based on MOSAIC Clinical Trial Demonstrati...ival in Stage III Colon Cancer Following ... BRIDGEWATER, N.J., Feb. 20 Sanofi-aventis,today ...on (FDA) has,accepted for filing and assigned prio...ication (sNDA) that proposes changes to the Eloxat...
Other Medicine Technology:Bionovo Announces Positive Developments in On-going Phase 1/2 Cancer Drug Trial 2Bionovo Announces Positive Developments in On-going Phase 1/2 Cancer Drug Trial 3Inclusion of Six-Year Overall Survival Data in the Eloxatin(R) (oxaliplatin injection) Prescribing Information Granted FDA Priority Review 2Inclusion of Six-Year Overall Survival Data in the Eloxatin(R) (oxaliplatin injection) Prescribing Information Granted FDA Priority Review 3
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
Medicine Products: